SEC Form 3 · accession 0001209191-17-038165
Axovant Sciences Ltd. · AXON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Frederick Mohr
Officer — General Counsel
Period of report
May 30, 2017
Accepted (ET)
Jun 6, 2017 · 5:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001636050
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney